Adeno-associated virus-based vectors in gene therapy

J Tal - Journal of Biomedical Science, 2000 - karger.com
Adeno-associated virus (AAV) vectors were shown capable of high efficiency transduction of
both dividing and nondividing cells and tissues. AAV-mediated transduction leads to stable …

Development and use of gene transfer for treatment of cardiovascular disease

AH Baker - Journal of cardiac surgery, 2002 - Wiley Online Library
Gene therapy holds promise for the treatment of cardiovascular diseases for which effective
pharmacological therapies are insufficient or unavailable. Recent studies have suggested …

Antisense inhibition of thyrotropin-releasing hormone reduces arterial blood pressure in spontaneously hypertensive rats

SI García, AL Alvarez, PI Porto, VM Garfunkel… - …, 2001 - Am Heart Assoc
Thyrotropin-releasing hormone (TRH) plays an important role in central cardiovascular
regulation. Recently, we described that the TRH precursor gene overexpression induces …

Thyrotropin-releasing hormone in cardiovascular pathophysiology

SI García, CJ Pirola - Regulatory peptides, 2005 - Elsevier
Thyrotropin (TSH)-releasing hormone (TRH) also known as thyroliberin was the first of a
number of peptides exerting several roles as a hormone and as a neuropeptide. Its …

Long-Term Inhibition of the Central α2B-Adrenergic Receptor Gene Via Recombinant AAV-Delivered Antisense in Hypertensive Rats

SM Shenouda, C Johns, I Gavras… - American journal of …, 2006 - academic.oup.com
Background: Salt-induced hypertension is mediated via the α2B-adrenergic receptor (AR)
subtype. In α2B-AR gene knockout mice, blood pressure (BP) does not rise with salt loading …

Vigilant cells

MI Phillips, YL Tang - US Patent 9,040,676, 2015 - Google Patents
Related US Application Data (60) Provisional application No. 60/494,184, filed on Aug. 11,
2003, provisional application No. 60/494,185, filed on Aug. 11, 2003, provisional application …

[HTML][HTML] The impact of molecular medicine upon early cardiovascular drug development

MW Lunnon, M Braddock - British journal of clinical pharmacology, 2000 - ncbi.nlm.nih.gov
Heart disease remains the leading cause of death and morbidity in the western world
despite significant advances in cardiovascular (CVS) therapeutics. Since the 1960s clinical …

The current status of antihypertensive treatments: into the new millennium

TC Hardman, MW Lunnon - Expert Opinion on Pharmacotherapy, 2001 - Taylor & Francis
In this short review, we present a historical perspective of the treatment of hypertension,
highlight some current issues and look to the possible future of antihypertensive therapy …

[图书][B] Long-term inhibition of the central alpha 2B-adrenergic receptor gene via recombinant adeno-associated virus-delivered antisense DNA in hypertensive rats

SM Shenouda - 2005 - search.proquest.com
The sympathetic nervous system (SNS) elicits its effects by controlling the release of
catecholamines, whose actions are mediated by their binding to adrenergic receptors (AR) …

Stem cell beacon

MI Phillips, YL Tang - US Patent 8,569,471, 2013 - Google Patents
The invention relates to methods and compositions for selec tively directing stem cells to a
target tissue within a subject using a system that employs one or more vectors that contain a …